Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ VanderbiltfiledCriticalUniv Vanderbilt
Priority claimed from PCT/US2021/024215external-prioritypatent/WO2021195418A1/en
Publication of MA57414B1publicationCriticalpatent/MA57414B1/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
La présente invention concerne des anticorps se liant au coronavirus désigné sars-cov-2 et le neutralisant, ainsi que des méthodes d'utilisation de ceux-ci.The present invention relates to antibodies binding to and neutralizing the coronavirus designated sars-cov-2, as well as methods of using the same.
MA57414A2020-03-262021-03-25
HUMAN MONOCLONAL ANTIBODIES AGAINST SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)
MA57414B1
(en)